Zilebesiran

Zilebesiran is an experimental small interfering RNA developed by Roche and Alnylam that is administered subcutaneously twice annually to lower blood pressure in people already taking other antihypertensive drugs. It works by impeding the synthesis of angiotensinogen in the liver.